Tomohiro Yoshimoto
Nishinomiya-hama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Lung fibroblasts produce IL-33 in response to stimulation with retinoblastoma-binding protein 9 via production of prostaglandin E2.
Journal: International immunology
Published: November 09, 2019
Regnase-1 degradation is crucial for IL-33- and IL-25-mediated ILC2 activation.
Journal: JCI insight
Published: July 01, 2019
Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis.
Journal: Frontiers in immunology
Published: June 11, 2019
Prostaglandin E2 (PGE2)-EP2 signaling negatively regulates murine atopic dermatitis-like skin inflammation by suppressing thymic stromal lymphopoietin expression.
Journal: The Journal of allergy and clinical immunology
Published: February 24, 2019
The Hunt for the Source of Primary Interleukin-4: How We Discovered That Natural Killer T Cells and Basophils Determine T Helper Type 2 Cell Differentiation In Vivo.
Journal: Frontiers in immunology
Published: January 29, 2018
Human cystatin SN is an endogenous protease inhibitor that prevents allergic rhinitis.
Journal: The Journal of allergy and clinical immunology
Published: December 26, 2017
MOLECULAR MECHANISMS FOR CUTANEOUSLY SENSITIZED FOOD ALLERGY : EXPERIMENTAL EVIDENCES FOR DUAL ALLERGEN EXPOSURE HYPOTHESIS
Journal: Arerugi = [Allergy]
Published: December 19, 2017
Barrier dysfunction in the nasal allergy.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: October 20, 2017
ENDOTOXINS INDUCE IgE-INDEPENDENT NASAL HYPERSENSITIVITY.
Journal: Arerugi = [Allergy]
Published: August 22, 2017
EXPERIMENTAL EVIDENCES FOR LOCAL ALLERGIC RHINITIS.
Journal: Arerugi = [Allergy]
Published: May 19, 2017
Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
Journal: Biochemical pharmacology
Published: February 16, 2017
Last Updated: 09/26/2026